Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?
The weight loss drug market is exploding, with new products entering the scene to compete with big names like Ozempic. It is ...
Researchers documented a six per cent to nine per cent decline in grocery spending within the first six months of the GLP-1 ...
Ozempic was originally approved to treat people with Type 2 diabetes, but demand has surged because of the drug’s weight-loss ...
Often patients reach their goal weight and feel good about themselves. Then, because of the initial success, they decide the ...
As Ozempic and other GLP-1 drugs explode in popularity, driven by their off-label use for rapid weight loss and viral social media trends, the pharmaceutical industry faces unprecedented challenges.